{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:24:24Z","timestamp":1792704264802,"version":"4.5.0"},"reference-count":53,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Gene expression profiles were examined in 33 adult patients with T-cell acute lymphocytic leukemia (T-ALL). Nonspecific filtering criteria identified 313 genes differentially expressed in the leukemic cells. Hierarchical clustering of samples identified 2 groups that reflected the degree of T-cell differentiation but was not associated with clinical outcome. Comparison between refractory patients and those who responded to induction chemotherapy identified a single gene, interleukin 8 (IL-8), that was highly expressed in refractory T-ALL cells and a set of 30 genes that was highly expressed in leukemic cells from patients who achieved complete remission. We next identified 19 genes that were differentially expressed in T-ALL cells from patients who either had a relapse or remained in continuous complete remission. A model based on the expression of 3 of these genes was predictive of duration of remission. The 3-gene model was validated on a further set of T-ALL samples from 18 additional patients treated on the same clinical protocol. This study demonstrates that gene expression profiling can identify a limited number of genes that are predictive of response to induction therapy and remission duration in adult patients with T-ALL. (Blood. 2004;103:2771-2778)<\/jats:p>","DOI":"10.1182\/blood-2003-09-3243","type":"journal-article","created":{"date-parts":[[2003,12,22]],"date-time":"2003-12-22T20:13:41Z","timestamp":1072124021000},"page":"2771-2778","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":270,"title":["Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival"],"prefix":"10.1182","volume":"103","author":[{"given":"Sabina","family":"Chiaretti","sequence":"first","affiliation":[{"name":"From the Departments of Medical Oncology and Biostatistical Science, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston MA; and Dipartimento di Biotecnologie Cellulari ed Ematologia, University \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Li","sequence":"additional","affiliation":[{"name":"From the Departments of Medical Oncology and Biostatistical Science, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston MA; and Dipartimento di Biotecnologie Cellulari ed Ematologia, University \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gentleman","sequence":"additional","affiliation":[{"name":"From the Departments of Medical Oncology and Biostatistical Science, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston MA; and Dipartimento di Biotecnologie Cellulari ed Ematologia, University \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Vitale","sequence":"additional","affiliation":[{"name":"From the Departments of Medical Oncology and Biostatistical Science, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston MA; and Dipartimento di Biotecnologie Cellulari ed Ematologia, University \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Vignetti","sequence":"additional","affiliation":[{"name":"From the Departments of Medical Oncology and Biostatistical Science, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston MA; and Dipartimento di Biotecnologie Cellulari ed Ematologia, University \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Mandelli","sequence":"additional","affiliation":[{"name":"From the Departments of Medical Oncology and Biostatistical Science, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston MA; and Dipartimento di Biotecnologie Cellulari ed Ematologia, University \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Ritz","sequence":"additional","affiliation":[{"name":"From the Departments of Medical Oncology and Biostatistical Science, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston MA; and Dipartimento di Biotecnologie Cellulari ed Ematologia, University \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Foa","sequence":"additional","affiliation":[{"name":"From the Departments of Medical Oncology and Biostatistical Science, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston MA; and Dipartimento di Biotecnologie Cellulari ed Ematologia, University \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218460841900_REF1","doi-asserted-by":"crossref","unstructured":"Faderl S, Kantarjian HM, Talpaz M, Estrov Z. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood. 1998;91: 3995-4019.","DOI":"10.1182\/blood.V91.11.3995"},{"key":"2020021218460841900_REF2","doi-asserted-by":"crossref","unstructured":"Kersey JH. Fifty years of studies of the biology and therapy of childhood leukemia. Blood. 1997;90: 4243-4251.","DOI":"10.1182\/blood.V90.11.4243"},{"key":"2020021218460841900_REF3","doi-asserted-by":"crossref","unstructured":"Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med. 1998;339: 605-615.","DOI":"10.1056\/NEJM199808273390907"},{"key":"2020021218460841900_REF4","doi-asserted-by":"crossref","unstructured":"Thiel E, Kranz BR, Raghavachar A, et al. Prethymic phenotype and genotype of pre-T (CD7+\/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia. Blood. 1989;73: 1247-1258.","DOI":"10.1182\/blood.V73.5.1247.1247"},{"key":"2020021218460841900_REF5","doi-asserted-by":"crossref","unstructured":"Bowtell DD. Options available\u2014from start to finish\u2014for obtaining expression data by microarray. Nat Genet. 1999;21: 25-32.","DOI":"10.1038\/4455"},{"key":"2020021218460841900_REF6","doi-asserted-by":"crossref","unstructured":"DeRisi J, Penland L, Brown PO, et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet. 1996;14: 457-460.","DOI":"10.1038\/ng1296-457"},{"key":"2020021218460841900_REF7","unstructured":"Zhang W, Laborde PM, Coombes KR, Berry DA, Hamilton SR. Cancer genomics: promises and complexities. Clin Cancer Res. 2001;7: 2159-2167."},{"key":"2020021218460841900_REF8","doi-asserted-by":"crossref","unstructured":"Dhanasekaran SM, Barrette TR, Ghosh D, et al. Delineation of prognostic biomarkers in prostate cancer. Nature. 2001;412: 822-826.","DOI":"10.1038\/35090585"},{"key":"2020021218460841900_REF9","doi-asserted-by":"crossref","unstructured":"Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999;286: 531-537.","DOI":"10.1126\/science.286.5439.531"},{"key":"2020021218460841900_REF10","doi-asserted-by":"crossref","unstructured":"Hedenfalk I, Duggan D, Chen Y, et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med. 2001;344: 539-548.","DOI":"10.1056\/NEJM200102223440801"},{"key":"2020021218460841900_REF11","doi-asserted-by":"crossref","unstructured":"Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 2001;194: 1625-1638.","DOI":"10.1084\/jem.194.11.1625"},{"key":"2020021218460841900_REF12","doi-asserted-by":"crossref","unstructured":"Miyazato A, Ueno S, Ohmine K, et al. Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction. Blood. 2001;98: 422-427.","DOI":"10.1182\/blood.V98.2.422"},{"key":"2020021218460841900_REF13","doi-asserted-by":"crossref","unstructured":"Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346: 1937-1947.","DOI":"10.1056\/NEJMoa012914"},{"key":"2020021218460841900_REF14","doi-asserted-by":"crossref","unstructured":"Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 2001;194: 1639-1647.","DOI":"10.1084\/jem.194.11.1639"},{"key":"2020021218460841900_REF15","doi-asserted-by":"crossref","unstructured":"Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 2002;1: 133-143.","DOI":"10.1016\/S1535-6108(02)00032-6"},{"key":"2020021218460841900_REF16","doi-asserted-by":"crossref","unstructured":"Shipp MA, Ross KN, Tamayo P, et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med. 2002;8: 68-74.","DOI":"10.1038\/nm0102-68"},{"key":"2020021218460841900_REF17","doi-asserted-by":"crossref","unstructured":"Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403: 503-511.","DOI":"10.1038\/35000501"},{"key":"2020021218460841900_REF18","doi-asserted-by":"crossref","unstructured":"Armstrong SA, Kung AL, Mabon ME, et al. Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification. Cancer Cell. 2003;3: 173-183.","DOI":"10.1016\/S1535-6108(03)00003-5"},{"key":"2020021218460841900_REF19","doi-asserted-by":"crossref","unstructured":"Tafuri A, Gregorj C, Petrucci MT, et al. MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. Blood. 2002;100: 974-981.","DOI":"10.1182\/blood-2001-12-0371"},{"key":"2020021218460841900_REF20","doi-asserted-by":"crossref","unstructured":"van Dongen JJ, Macintyre EA, Gabert JA, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia. 1999;13: 1901-1928.","DOI":"10.1038\/sj.leu.2401592"},{"key":"2020021218460841900_REF21","unstructured":"Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995;9: 1783-1786."},{"key":"2020021218460841900_REF22","doi-asserted-by":"crossref","unstructured":"Husson H, Carideo EG, Neuberg D, et al. Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays. Blood. 2002;99: 282-289.","DOI":"10.1182\/blood.V99.1.282"},{"key":"2020021218460841900_REF23","doi-asserted-by":"crossref","unstructured":"Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A. 2001;98: 31-36.","DOI":"10.1073\/pnas.98.1.31"},{"key":"2020021218460841900_REF24","doi-asserted-by":"crossref","unstructured":"Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A. 1998;95: 14863-14868.","DOI":"10.1073\/pnas.95.25.14863"},{"key":"2020021218460841900_REF25","doi-asserted-by":"crossref","unstructured":"Ihaka GR, Gentleman R. R: a language for data analysis and graphics. J Comput Graphical Stat. 1996;5: 299-314.","DOI":"10.1080\/10618600.1996.10474713"},{"key":"2020021218460841900_REF26","doi-asserted-by":"crossref","unstructured":"Venables WN, Ripley BD. Modern Applied Statistics with S-PLUS. New York, NY: Springer; 1999.","DOI":"10.1007\/978-1-4757-3121-7"},{"key":"2020021218460841900_REF27","doi-asserted-by":"crossref","unstructured":"Cutrona G, Tasso P, Dono M, et al. CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL. Br J Cancer. 2002;86: 1776-1785.","DOI":"10.1038\/sj.bjc.6600329"},{"key":"2020021218460841900_REF28","doi-asserted-by":"crossref","unstructured":"Lenormand B, Bene MC, Lesesve JF, et al. PreB1 (CD10-) acute lymphoblastic leukemia: immunophenotypic and genomic characteristics, clinical features and outcome in 38 adults and 26 children. The Groupe dEtude Immunologique des Leucemies. Leuk Lymphoma. 1998;28: 329-342.","DOI":"10.3109\/10428199809092688"},{"key":"2020021218460841900_REF29","doi-asserted-by":"crossref","unstructured":"Shuster JJ, Falletta JM, Pullen DJ, et al. Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood. 1990;75: 166-173.","DOI":"10.1182\/blood.V75.1.166.166"},{"key":"2020021218460841900_REF30","doi-asserted-by":"crossref","unstructured":"Shtivelman E, Cohen FE, Bishop JM. A human gene (AHNAK) encoding an unusually large protein with a 1.2-microns polyionic rod structure. Proc Natl Acad Sci U S A. 1992;89: 5472-5476.","DOI":"10.1073\/pnas.89.12.5472"},{"key":"2020021218460841900_REF31","unstructured":"Hoelzer D, Gokbuget N. New approaches to acute lymphoblastic leukemia in adults: where do we go? Semin Oncol. 2000;27: 540-559."},{"key":"2020021218460841900_REF32","doi-asserted-by":"crossref","unstructured":"Ferrando AA, Neuberg DS, Staunton J, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 2002;1: 75-87.","DOI":"10.1016\/S1535-6108(02)00018-1"},{"key":"2020021218460841900_REF33","doi-asserted-by":"crossref","unstructured":"Asnafi V, Beldjord K, Boulanger E, et al. Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood. 2003;101: 2693-2703.","DOI":"10.1182\/blood-2002-08-2438"},{"key":"2020021218460841900_REF34","doi-asserted-by":"crossref","unstructured":"di Celle PF, Mariani S, Riera L, Stacchini A, Reato G, Foa R. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood. 1996;87: 4382-4389.","DOI":"10.1182\/blood.V87.10.4382.bloodjournal87104382"},{"key":"2020021218460841900_REF35","doi-asserted-by":"crossref","unstructured":"di Celle PF, Carbone A, Marchis D, et al. Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein. Blood. 1994;84: 220-228.","DOI":"10.1182\/blood.V84.1.220.220"},{"key":"2020021218460841900_REF36","unstructured":"Molica S, Vitelli G, Levato D, Levato L, Dattilo A, Gandolfo GM. Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia. Haematologica. 1999;84: 208-211."},{"key":"2020021218460841900_REF37","unstructured":"Liu J, Zeng H, Zhang Y. [Study on the expression of interleukin-8 and its receptors in acute leukemia]. Zhonghua Xue Ye Xue Za Zhi. 1999;20: 24-26."},{"key":"2020021218460841900_REF38","doi-asserted-by":"crossref","unstructured":"Kudoh J, Wang Y, Minoshima S, et al. Localization of the human AHNAK\/desmoyokin gene (AHNAK) to chromosome band 11q12 by somatic cell hybrid analysis and fluorescence in situ hybridization. Cytogenet Cell Genet. 1995;70: 218-220.","DOI":"10.1159\/000134037"},{"key":"2020021218460841900_REF39","doi-asserted-by":"crossref","unstructured":"Gentil BJ, Delphin C, Mbele GO, et al. The giant protein AHNAK is a specific target for the calcium- and zinc-binding S100B protein: potential implications for Ca2+ homeostasis regulation by S100B. J Biol Chem. 2001;276: 23253-23261.","DOI":"10.1074\/jbc.M010655200"},{"key":"2020021218460841900_REF40","doi-asserted-by":"crossref","unstructured":"Sussman J, Stokoe D, Ossina N, Shtivelman E. Protein kinase B phosphorylates AHNAK and regulates its subcellular localization. J Cell Biol. 2001;154: 1019-1030.","DOI":"10.1083\/jcb.200105121"},{"key":"2020021218460841900_REF41","doi-asserted-by":"crossref","unstructured":"Mills GB, Schmandt R, McGill M, et al. Expression of TTK, a novel human protein kinase, is associated with cell proliferation. J Biol Chem. 1992;267: 16000-16006.","DOI":"10.1016\/S0021-9258(19)49633-6"},{"key":"2020021218460841900_REF42","unstructured":"Hogg D, Guidos C, Bailey D, et al. Cell cycle dependent regulation of the protein kinase TTK. Oncogene. 1994;9: 89-96."},{"key":"2020021218460841900_REF43","doi-asserted-by":"crossref","unstructured":"Castillo AR, Meehl JB, Morgan G, Schutz-Geschwender A, Winey M. The yeast protein kinase Mps1p is required for assembly of the integral spindle pole body component Spc42p. J Cell Biol. 2002;156: 453-465.","DOI":"10.1083\/jcb.200111025"},{"key":"2020021218460841900_REF44","doi-asserted-by":"crossref","unstructured":"Moingeon P, Chang HC, Sayre PH, et al. The structural biology of CD2. Immunol Rev. 1989;111: 111-144.","DOI":"10.1111\/j.1600-065X.1989.tb00544.x"},{"key":"2020021218460841900_REF45","doi-asserted-by":"crossref","unstructured":"Lobach DF, Hensley LL, Ho W, Haynes BF. Human T cell antigen expression during the early stages of fetal thymic maturation. J Immunol. 1985;135: 1752-1759.","DOI":"10.4049\/jimmunol.135.3.1752"},{"key":"2020021218460841900_REF46","doi-asserted-by":"crossref","unstructured":"Sasada T, Reinherz EL. A critical role for CD2 in both thymic selection events and mature T cell function. J Immunol. 2001;166: 2394-2403.","DOI":"10.4049\/jimmunol.166.4.2394"},{"key":"2020021218460841900_REF47","doi-asserted-by":"crossref","unstructured":"Yang H, Reinherz EL. Dynamic recruitment of human CD2 into lipid rafts. Linkage to T cell signal transduction. J Biol Chem. 2001;276: 18775-18785.","DOI":"10.1074\/jbc.M009852200"},{"key":"2020021218460841900_REF48","doi-asserted-by":"crossref","unstructured":"Dustin ML. Membrane domains and the immunological synapse: keeping T cells resting and ready. J Clin Invest. 2002;109: 155-160.","DOI":"10.1172\/JCI0214842"},{"key":"2020021218460841900_REF49","unstructured":"Bowden G, LA Diaz, LL Li, Fox D. Epitopes and functional responses defined by workshop anti-CD2 in monoclonal antibodies. In: Schlossman SF BL, Gilks W, Harlan JM, et al, eds. Leucocyte Typing V: White Cell Differentiation Antigens. Vol. 1. Oxford, United Kingdom: Oxford University Press; 1995: 346-347."},{"key":"2020021218460841900_REF50","doi-asserted-by":"crossref","unstructured":"Schmidt RE, Michon JM, Woronicz J, Schlossman SF, Reinherz EL, Ritz J. Enhancement of natural killer function through activation of the T11 E rosette receptor. J Clin Invest. 1987;79: 305-308.","DOI":"10.1172\/JCI112800"},{"key":"2020021218460841900_REF51","doi-asserted-by":"crossref","unstructured":"Siliciano RF, Pratt JC, Schmidt RE, Ritz J, Reinherz EL. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature. 1985;317: 428-430.","DOI":"10.1038\/317428a0"},{"key":"2020021218460841900_REF52","doi-asserted-by":"crossref","unstructured":"Uckun FM, Steinherz PG, Sather H, et al. CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: a Children's Cancer Group study. Blood. 1996;88: 4288-4295.","DOI":"10.1182\/blood.V88.11.4288.bloodjournal88114288"},{"key":"2020021218460841900_REF53","doi-asserted-by":"crossref","unstructured":"Ballerini P, Blaise A, Busson-Le Coniat M, et al. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Blood. 2002;100: 991-997.","DOI":"10.1182\/blood-2001-11-0093"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/7\/2771\/1697422\/zh800704002771.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/7\/2771\/1697422\/zh800704002771.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T13:26:54Z","timestamp":1734182814000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/103\/7\/2771\/18318\/Gene-expression-profile-of-adult-Tcell-acute"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,1]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,4,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-09-3243","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,1]]}}}